Evidence map›Paper›PMID 35008449›Full record

ArticleInternational journal of molecular sciences2021

A Novel Antimicrobial Peptide Sparanegtin Identified in

Xuewu Zhu, Fangyi Chen, Shuang Li, Hui Peng, Ke-Jian Wang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Newly Discovered Antimicrobial Peptide ScyampcinAntimicrobial agents and chemotherapy · 2023
    Article
  4. Review
  5. A Novel Antimicrobial Peptide SpampcinInternational journal of molecular sciences · 2022
    Article
  6. Article
  7. Frontiers in Antimicrobial Biomaterials.International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Xuewu ZhuState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361005, China.
Fangyi ChenState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361005, China.
Shuang LiState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361005, China.
Hui PengState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361005, China.
Ke-Jian WangState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen 361005, China.
Xiamen University · CN

Funding

Fujian Marine Economic Development Subsidy Fund Project FJHJF-L-2019-1Fujian Ocean and Fisheries Department, the Xiamen Ocean and Fishery Development Special Fund Project 20CZP011HJ06Fundamental Research Funds from Central Universities 20720190109National Natural Science Foundation of China U1805233Xiamen Science and Technology Planning Project 3502Z20203012
6 · The paper itself

Abstract

The abuse of antibiotics in aquaculture and livestock no doubt has exacerbated the increase in antibiotic-resistant bacteria, which imposes serious threats to animal and human health. The exploration of substitutes for antibiotics from marine animals has become a promising area of research, and antimicrobial peptides (AMPs) are worth investigating and considering as potential alternatives to antibiotics. In the study, we identified a novel AMP gene from the mud crab

Indexed as

AnimalsAntimicrobial PeptidesArthropod ProteinsBrachyuraGram-Negative BacteriaGram-Positive BacteriaLipopolysaccharidesMaleMicrobial ViabilityRecombinant ProteinsTestisTissue DistributionUp-RegulationVibrio alginolyticusAntimicrobial PeptidesArthropod ProteinsLipopolysaccharidesRecombinant Proteinsantimicrobial activityantimicrobial peptideimmunoprotective roleScylla paramamosainSparanegtin

Identifiers

PMID35008449
PMCPMC8744658
OpenAlexW4200067903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.